Details for Patent: 9,186,411
✉ Email this page to a colleague
Which drugs does patent 9,186,411 protect, and when does it expire?
Patent 9,186,411 protects VOQUEZNA TRIPLE PAK, VOQUEZNA DUAL PAK, and VOQUEZNA, and is included in three NDAs.
This patent has forty-five patent family members in twenty-eight countries.
Summary for Patent: 9,186,411
| Title: | Pharmaceutical composition |
| Abstract: | The present invention provides a pharmaceutical composition or a solid preparation containing a stabilized pharmaceutically active ingredient and a stabilizing method thereof. According to the present invention, a pharmaceutical composition can be stabilized by containing a nonpeptidic pharmaceutically active ingredient having a primary or secondary amino group, an excipient and an acidic compound. In addition, a solid preparation containing a pharmaceutically active ingredient, titanium oxide, a plasticizer and a chain organic acid can enhance the stability of the pharmaceutically active ingredient during light irradiation. |
| Inventor(s): | Hiraishi; Yasuhiro (Osaka, JP), Nonomura; Muneo (Osaka, JP) |
| Assignee: | Takeda Pharmaceutical Company Limited (Osaka-Shi, JP) |
| Application Number: | 13/056,593 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 9,186,411
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Phathom | VOQUEZNA TRIPLE PAK | amoxicillin; clarithromycin; vonoprazan fumarate | CAPSULE, TABLET, TABLET;ORAL | 215152-001 | May 3, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Phathom | VOQUEZNA DUAL PAK | amoxicillin; vonoprazan fumarate | CAPSULE, TABLET;ORAL | 215153-001 | May 3, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Phathom | VOQUEZNA | vonoprazan fumarate | TABLET;ORAL | 215151-001 | Nov 1, 2023 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Phathom | VOQUEZNA | vonoprazan fumarate | TABLET;ORAL | 215151-002 | Nov 1, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,186,411
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 2008-194219 | Jul 28, 2008 |
| PCT Information | |||
| PCT Filed | July 27, 2009 | PCT Application Number: | PCT/JP2009/063708 |
| PCT Publication Date: | February 04, 2010 | PCT Publication Number: | WO2010/013823 |
International Family Members for US Patent 9,186,411
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 072842 | ⤷ Sign Up | |||
| Australia | 2009277443 | ⤷ Sign Up | |||
| Brazil | PI0916689 | ⤷ Sign Up | |||
| Canada | 2732243 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
